Estrogen Receptors/SERMs - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

Understanding Cancer Series: Estrogen Receptors/SERMs

Posted: 01/28/2005 Updated: 04/27/2006 Reviewed: 09/01/2006

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

Quit Smoking Today

	NCI Highlights


	Report to Nation Finds Declines in Cancer Incidence, Death Rates High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E The Nation's Investment in Cancer Research FY 2009 Past Highlights

Estrogen Receptors/SERMs

Slide Number and Title

What Are Estrogens?
Estrogen Target Tissues
Estrogen Receptors
Estrogen Receptors Trigger Gene Activation
Estrogen-Induced Changes in Cell Behavior
Estrogen-Induced Stimulation of Cell Proliferation
Estrogen and Cancer
Estrogen and Breast Cancer
Cancer Arises From DNA Mutations In Cells
Estrogen-Induced Proliferation of Existing Mutant Cells
Estrogen-Induced Proliferation and Spontaneous New Mutations
Estrogen and Uterine Cancer
Antiestrogens

SERMs
Tamoxifen and Cancer
Tamoxifen and Breast Cancer Treatment
Estrogen Receptor-Negative Breast Cancer
Tamoxifen and Breast Cancer Prevention
Tamoxifen as a Cause of Uterine Cancer
The Need for Better SERMs
Estrogen Replacement During Menopause
Estrogen Plus Progesterone Replacement
Search for the Perfect SERM
Raloxifene and the Prevention of Osteoporosis
Raloxifene and Risk of Invasive Breast Cancer

| | | | | | | |

A Service of the National Cancer Institute